Publicaciones en las que colabora con JUDIT PALLARES QUIXAL (17)

2024

  1. Influence of nonalcoholic fatty liver disease severity on carotid adventitial vasa vasorum

    Frontiers in Endocrinology, Vol. 15

2016

  1. The role of morbid obesity in the promotion of metabolic disruptions and non-alcoholic steatohepatitis by helicobacter pylori

    PLoS ONE, Vol. 11, Núm. 11

2013

  1. An inducible knockout mouse to model the cell-autonomous role of PTEN in initiating endometrial, prostate and thyroid neoplasias

    DMM Disease Models and Mechanisms, Vol. 6, Núm. 3, pp. 710-720

2011

  1. KSR1 is overexpressed in endometrial carcinoma and regulates proliferation and TRAIL-induced apoptosis by modulating FLIP levels

    American Journal of Pathology, Vol. 178, Núm. 4, pp. 1529-1543

2010

  1. Squamous cell carcinoma developing in Jadassohn's sebaceous nevus: Case report and review of the literature

    Dermatologic Surgery, Vol. 36, Núm. 11, pp. 1763-1768

  2. The multikinase inhibitor Sorafenib induces apoptosis and sensitises endometrial cancer cells to TRAIL by different mechanisms

    European Journal of Cancer, Vol. 46, Núm. 4, pp. 836-850

2009

  1. A review of the applications of tissue microarray technology in understanding the molecular features of endometrial carcinoma

    Analytical and Quantitative Cytology and Histology, Vol. 31, Núm. 4, pp. 217-226

  2. CK2β is expressed in endometrial carcinoma and has a role in apoptosis resistance and cell proliferation

    American Journal of Pathology, Vol. 174, Núm. 1, pp. 287-296

  3. Molecular pathology of endometrial carcinoma: Practical aspects from the diagnostic and therapeutic viewpoints

    Journal of Clinical Pathology, Vol. 62, Núm. 9, pp. 777-785

2008

  1. CK2 controls TRAIL and Fas sensitivity by regulating FLIP levels in endometrial carcinoma cells

    Oncogene, Vol. 27, Núm. 18, pp. 2513-2524

  2. Loss of heterozygosity in endometrial carcinoma

    International Journal of Gynecological Pathology, Vol. 27, Núm. 3, pp. 305-317

  3. Nuclear factor-κB activation is associated with somatic and germ line RET mutations in medullary thyroid carcinoma

    Human Pathology, Vol. 39, Núm. 7, pp. 994-1001

  4. Promoter hypermethylation and reduced expression of RASSF1A are frequent molecular alterations of endometrial carcinoma

    Modern Pathology, Vol. 21, Núm. 6, pp. 691-699

  5. Targeted therapies in gynecologic cancers and melanoma

    Seminars in Diagnostic Pathology, Vol. 25, Núm. 4, pp. 262-273

2007

  1. Mitral endocarditis due to Escherichia coli [4]

    Enfermedades Infecciosas y Microbiologia Clinica

  2. Nuevas dianas terapéuticas en el melanoma

    Piel, Vol. 22, Núm. 4, pp. 205-211

2006

  1. Antiproliferative effect of STI571 on cultured human cutaneous melanoma-derived cell lines

    Melanoma Research, Vol. 16, Núm. 2, pp. 127-135